PerkinElmer to acquire Caliper Life Sciences

PerkinElmer has recently signed an agreement to acquire Caliper Life Sciences Inc., (Hopkinton, Massachusetts), a leader in imaging and detection solutions for life sciences, research, diagnostics and environmental markets for a total net purchase price of approximately $600 million in cash.

Commenting on the acquisition, Robert F. Friel, chairman and chief executive officer, PerkinElmer, said, “The R&D, application expertise and intellectual property of the combined organization will provide our customers with enhanced knowledge and services and a strong pipeline of innovation. Additionally, the proven leadership and talent of the Caliper team will be a strong addition to our organization.”

As a result of the agreement, the company will be able to provide a number of additional services including further scope for molecular, cellular, animal and tissue imaging to enable translational medicine research; high-value sample preparation technologies for key scientific workflow areas such as next generation DNA sequencing and expansion into areas such as the detection of environmental contaminants and food pathogens.

Kevin Hrusovsky, chief executive officer, Caliper Life Sciences expressed his delight at becoming part of PerkinElmer and the opportunities that this will open up for making advances into improving human and environmental health.

For more information visit www.perkinelmer.com